Your browser doesn't support javascript.
loading
A high prostatic-specific antigen with a large pelvic mass indicates a prostatic cystadenocarcinoma.
Di Maida, Fabrizio; Grosso, Antonio Andrea; Crisci, Alfonso; Mari, Andrea; Carini, Marco; Minervini, Andrea.
Afiliación
  • Di Maida F; Department of Experimental and Clinical Medicine, University of Florence - Unit of Oncologic Minimally-Invasive Urology and Andrology, Careggi Hospital, Florence, Italy.
  • Grosso AA; Department of Experimental and Clinical Medicine, University of Florence - Unit of Oncologic Minimally-Invasive Urology and Andrology, Careggi Hospital, Florence, Italy.
  • Crisci A; Department of Experimental and Clinical Medicine, University of Florence - Unit of Oncologic Minimally-Invasive Urology and Andrology, Careggi Hospital, Florence, Italy.
  • Mari A; Department of Experimental and Clinical Medicine, University of Florence - Unit of Oncologic Minimally-Invasive Urology and Andrology, Careggi Hospital, Florence, Italy.
  • Carini M; Department of Experimental and Clinical Medicine, University of Florence - Unit of Oncologic Minimally-Invasive Urology and Andrology, Careggi Hospital, Florence, Italy.
  • Minervini A; Department of Experimental and Clinical Medicine, University of Florence - Unit of Oncologic Minimally-Invasive Urology and Andrology, Careggi Hospital, Florence, Italy. Electronic address: andreamine@libero.it.
Lancet ; 398(10312): 1726, 2021 11 06.
Article en En | MEDLINE | ID: mdl-34742383
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Próstata / Neoplasias de la Próstata / Antígeno Prostático Específico / Cistadenocarcinoma Límite: Humans / Male Idioma: En Revista: Lancet Año: 2021 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Próstata / Neoplasias de la Próstata / Antígeno Prostático Específico / Cistadenocarcinoma Límite: Humans / Male Idioma: En Revista: Lancet Año: 2021 Tipo del documento: Article País de afiliación: Italia